Food and Drug Administration (FDA) Revision of USP Chapter on Gene Therapy Medicinal Products (Catapult’s regulatory round-up – October 2024)
This chapter covers the clinical applications, manufacturing processes and analytical methods of gene therapy products, which are constantly evolving. The current amendment proposals include, for example, the following points: Delete the reference to “Safety Tests-Biologicals”...





